Jiangsu Lianhuan Pharmaceutical Co., Ltd. (SHA:600513)

China flag China · Delayed Price · Currency is CNY
22.61
+0.72 (3.29%)
Apr 30, 2026, 11:30 AM CST
154.33%
Market Cap 6.25B
Revenue (ttm) 2.71B
Net Income (ttm) -98.33M
Shares Out 285.46M
EPS (ttm) -0.34
PE Ratio n/a
Forward PE n/a
Dividend 0.09 (0.43%)
Ex-Dividend Date Jun 23, 2025
Volume 25,024,936
Average Volume 29,040,253
Open 22.51
Previous Close 21.89
Day's Range 21.85 - 23.22
52-Week Range 8.65 - 32.27
Beta 0.18
RSI 51.43
Earnings Date Apr 21, 2026

About SHA:600513

Jiangsu Lianhuan Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells pharmaceuticals, preparations, and active pharmaceutical ingredients (API) products in China and internationally. The company offers clopidogrel bisulfate tablets, doxycycline hydrochloride, azithromycin, milrinone, dapoxetine hydrochloride, tadalafil, and betasine besylate tablets, as well as aprilite, danazol suppositories, and terfenadine tablets. It also provides urinary system drugs, including eprepitant tablets, terazosin tablets, and drotave... [Read more]

Sector Healthcare
Founded 1999
Employees 1,388
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600513
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.